A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Clinical trial NCT05226507 · TERMINATED

Trial details

NCT number: NCT05226507
Sponsor: Nuvectis Pharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Ovarian Cancer Ovarian Clear Cell Carcinoma Ovarian Clear Cell Tumor Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Endometrioid Tumor ARID1A Gene Mutation

Start date: 2021-12-31
Primary completion: 2025-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.